Life Sciences
Beaten-Down Bio-Rad Laboratories Shows Improvement, but Be Patient
The maker of life science research and clinical diagnostic products could trade sideways for awhile before a sustained advance begins.
Pacific Biosciences Has Made a Bottom Pattern: Prices to Watch
The stock bottomed in June/July and have worked higher.
Shares of Illumina Have Been Bottoming
Will we see a move from aggressive selling to aggressive buying?
Bearish Bets: A Chip Giant and 2 Other Stocks You Should Think About Shorting
These recently downgraded names are displaying both quantitative and technical deterioration.
A Fresh Look at Medical Device Maker DexCom After Earnings
The shares gapped higher Friday to refresh the uptrend.
Struggling 3M Needs to Form a Base, but Lowered Guidance Won't Help
The diversified technology giant has been bearish for months and is likely to remain so after reducing its full-year revenue and profit forecasts.
Bearish Bets: 3 Stocks You Should Think About Shorting This Week
These recently downgraded names are displaying both quantitative and technical deterioration.
Harmony Biosciences Could Soon Sing an Uplifting Tune
Here's our trading strategy for the shares.
My Chart Intel Says to Shy Away From Intellia Therapeutics
The technical signals of the genome editing company are largely bearish and indicate its stock is poised to weaken.
We're Changing Our DexCom Strategy as the Shares Move Higher
Here's what traders should do now.